Strategia Therapeutics, Inc.

Industry

  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Drug Discovery Technologies
      • ADMET
  • Services
  • Contract Research Organization-CRO
  • Distributors

Other Names/Subsidiaries

  • Boston Strategics
  • VITRAC Therapeutics
See more in Biomedtracker

Latest on Strategia Therapeutics, Inc.

In Vivo

Biopharma Quarterly Dealmaking Statistics, Q1 2016

 
• By Maureen Riordan and Amanda Micklus

Financings During the first quarter of 2016, biopharma financing totaled $5.7 billion, a 56% decrease over the previous quarter's $13.1 billion. (Keep in mind, over half of the Q4 2015 total came from

In Vivo

Deals Shaping The Medical Industry, March 2016

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc

In Vivo

Deals Shaping the Medical Industry, February 2016

IN VITRO DIAGNOSTICS Mergers & Acquisitions Abbott Laboratories Inc. Alere Inc. Abbott Laboratories Inc. is paying $56 per share (a 50% premium) or $5.8bn to acquire fellow public firm Alere Inc

In Vivo

Deals Shaping The Medical Industry, September 2014

IN VITRO DIAGNOSTICS Mergers & Acquisitions Danaher Corp. Beckman Coulter Inc. Siemens AG Siemens Healthcare Diagnostics Inc. Danaher Corp.’s Beckman Coulter Inc. bought Siemens Healthcare Diagnostics